• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

κ阿片受体激动剂U-50488H对大鼠缺血性脑水肿的保护作用

Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonist.

作者信息

Silvia R C, Slizgi G R, Ludens J H, Tang A H

出版信息

Brain Res. 1987 Feb 10;403(1):52-7. doi: 10.1016/0006-8993(87)90121-1.

DOI:10.1016/0006-8993(87)90121-1
PMID:3030502
Abstract

U-50488 is a specific kappa opioid agonist which produces in rats water diuresis resulting in an elevation of plasma osmolarity. Pretreatment with U-50488H (the methanesulfonate salt) in Fisher rats prior to 4 h of bilateral carotid occlusion prevented the development of edema in the forebrain, and the effect was greater than that from pentobarbital anesthesia. An additional injection of an antidiuretic hormone which prevented the plasma hyperosmolarity also significantly reduced the anticerebral edemic effects of U-50488H. The plasma osmotic effect, however, may not completely account for the ischemic protection produced by U-50488H.

摘要

U - 50488是一种特异性κ阿片受体激动剂,它在大鼠体内可产生水利尿作用,导致血浆渗透压升高。在双侧颈动脉闭塞4小时之前,用U - 50488H(甲磺酸盐)对费希尔大鼠进行预处理,可预防前脑水肿的发生,且该效果比戊巴比妥麻醉的效果更显著。额外注射一种抗利尿激素,可防止血浆渗透压升高,这也显著降低了U - 50488H的抗脑水肿作用。然而,血浆渗透效应可能无法完全解释U - 50488H所产生的缺血保护作用。

相似文献

1
Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonist.κ阿片受体激动剂U-50488H对大鼠缺血性脑水肿的保护作用
Brain Res. 1987 Feb 10;403(1):52-7. doi: 10.1016/0006-8993(87)90121-1.
2
Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.清醒大鼠中脑κ阿片受体诱发的肾功能变化:肾神经的参与
J Pharmacol Exp Ther. 1993 Oct;267(1):197-204.
3
Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury.
Brain Res. 1987 Dec 1;435(1-2):174-80. doi: 10.1016/0006-8993(87)91599-x.
4
Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus.通过向室旁核各亚区域微量注射κ-阿片类药物U-50488H [(反式-3,4-二氯-N-甲基-N-[2-(1-吡咯烷基)环己基]-苯乙酰胺)甲磺酸盐]所产生的不同心血管和肾脏反应。
J Pharmacol Exp Ther. 2005 Feb;312(2):678-85. doi: 10.1124/jpet.104.076828. Epub 2004 Sep 20.
5
Biochemical and functional interactions of a selective kappa opioid agonist with calcium.
Adv Exp Med Biol. 1987;221:345-55. doi: 10.1007/978-1-4684-7618-7_24.
6
The kappa opioid-related anticonvulsants U-50488H and U-54494A attenuate N-methyl-D-aspartate induced brain injury in the neonatal rat.与κ阿片样物质相关的抗惊厥药U-50488H和U-54494A可减轻新生大鼠中N-甲基-D-天冬氨酸诱导的脑损伤。
Brain Res. 1991 Nov 15;564(2):261-7. doi: 10.1016/0006-8993(91)91462-a.
7
Potential protection by a specific kappa-opiate agonist U-50488H against membrane failure in acute ischemic brain.
Neurol Med Chir (Tokyo). 1993 Mar;33(3):133-8. doi: 10.2176/nmc.33.133.
8
Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats.肾神经在清醒自发性高血压大鼠对κ激动剂给药的排泄反应中的作用。
J Pharmacol Exp Ther. 1989 Oct;251(1):230-7.
9
Effect of the anticonvulsant U-54494A on cortical neuron excitability: comparison to the kappa agonist U-50488H.抗惊厥药U-54494A对皮质神经元兴奋性的影响:与κ激动剂U-50488H的比较。
Life Sci. 1992;50(17):1225-33. doi: 10.1016/0024-3205(92)90322-g.
10
Protection from cerebral ischemia by U-50,488E, a specific kappa opioid analgesic agent.特异性κ阿片类镇痛药U-50,488E对脑缺血的保护作用。
Life Sci. 1985 Oct 21;37(16):1475-82. doi: 10.1016/0024-3205(85)90178-x.

引用本文的文献

1
The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.κ阿片受体:多种病症的一个有前景的治疗靶点。
Front Pharmacol. 2022 Jun 20;13:837671. doi: 10.3389/fphar.2022.837671. eCollection 2022.
2
κ‑opioid receptor agonist U50488H attenuates postoperative cognitive dysfunction of cardiopulmonary bypass rats through the PI3K/AKT/Nrf2/HO‑1 pathway.κ-阿片受体激动剂 U50488H 通过 PI3K/AKT/Nrf2/HO-1 通路减轻心肺转流大鼠术后认知功能障碍。
Mol Med Rep. 2021 Apr;23(4). doi: 10.3892/mmr.2021.11933. Epub 2021 Mar 2.
3
Kappa Opioid Agonist-Induced Diuresis: Characteristics, Mechanisms, and Beyond.
κ 阿片受体激动剂诱导的利尿作用:特征、机制及其他。
Handb Exp Pharmacol. 2022;271:401-417. doi: 10.1007/164_2020_399.
4
Spinocerebellar ataxia type 23 (SCA23): a review.脊髓小脑性共济失调 23 型(SCA23):综述。
J Neurol. 2021 Dec;268(12):4630-4645. doi: 10.1007/s00415-020-10297-5. Epub 2020 Nov 11.
5
Therapeutic Potential of Kappa Opioid Agonists.κ阿片受体激动剂的治疗潜力
Pharmaceuticals (Basel). 2019 Jun 20;12(2):95. doi: 10.3390/ph12020095.
6
Kappa Opioid Receptor Agonist and Brain Ischemia.κ阿片受体激动剂与脑缺血
Transl Perioper Pain Med. 2014;1(2):27-34.
7
Pathobiology of dynorphins in trauma and disease.强啡肽在创伤和疾病中的病理生物学
Front Biosci. 2005 Jan 1;10:216-35. doi: 10.2741/1522.
8
Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist.GR89696(一种高效且选择性的κ-阿片受体激动剂)的神经保护作用
Br J Pharmacol. 1991 Jul;103(3):1819-23. doi: 10.1111/j.1476-5381.1991.tb09869.x.